Dr. Reddy’s Laboratories features the launch of the palonosetron hydrochloride injection, 0.25 mg (base)/5 mL, a therapeutic equivalent generic version of ALOXI (palonosetron hydrochloride) injection, approved by the US Food and Drug Administration. Dr. Reddy’s palonosetron hydrochloride injection is available in a strength of 0.25 mg/5 mL (free base) in a single-dose vial packaged in a carton containing one vial.